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Abstract 
Background: Diabetes and periodontitis are chronic non-communicable diseases that are 
independently associated with mortality and have a bi-directional relationship, whereby 
each disease is associated with the other disease leading to poorer disease status. The 
relationship between periodontitis and diabetes was defined by an international workshop 
in 2012 and guidelines were produced. Since then, substantial new evidence has emerged 
for their inter-relationship. 
Aims: To update the evidence for epidemiological and mechanistic associations between 
periodontitis and diabetes and re-examine the impact of effective periodontal therapy upon 
metabolic control (HbA1C.  
Epidemiology: There is strong evidence that people with periodontitis have elevated risk 
for dysglycemia and insulin resistance. Cohort studies among people with diabetes 
demonstrate significantly higher HbA1C levels in periodontitis patients (vs. periodontally 
healthy), but there is insufficient data among people with type 1 diabetes. Periodontitis is 
also associated with an increased risk of incident type 2 diabetes. The co-morbid presence 
of periodontitis with diabetes imparts a higher risk of microvascular and macrovascular 
(nephropathy) complications and is associated with significantly higher all-cause and 
cardiovascular mortality.  
Mechanisms: Mechanistic links between periodontitis and diabetes involve elevations in 
interleukin (IL) 1-β, tumor necrosis factor-α, IL-6, receptor activator of nuclear factor-
kappa B ligand/osteoprotegerin ratio, oxidative stress and toll-like receptor (TLR)2/4 
expression.  
Interventions: periodontal therapy is safe and effective in people with diabetes and it is 
associated with reductions in HbA1C of 0.27-0.48% after 3-months, although studies 
involving longer-term follow up are inconclusive. 
Conclusions: Based on the most contemporary literature, the European Federation of 
Periodontology (EFP) and the International Diabetes Federation (IDF) report consensus 
guidelines for physicians, oral health care professionals and patients in order to improve 
rates of diagnosis for diabetes and pre-diabetes, and also to improve periodontal outcomes 
in people with diabetes. 
 
 
 
Clinical Relevance 
Scientific Rationale for Study 
Periodontitis and diabetes are chronic non-communicable diseases that impact upon the 
course and outcome of each other and also appear to interact in a manner that increases the 
risk of all-cause and cardiovascular mortality. This joint workshop between the European 
Federation of Periodontology (EFP) and the International Diabetes Federation (IDF) 
updated the evidence from the international EFP/AAP workshop in 2012 and developed 
consensus statements about the relationship between these two important diseases. 
Principal Findings 
Poor glycaemic control in diabetes is associated with poorer periodontal status and 
outcomes. Periodontitis is associated with disglycaemia and increased insulin resistance in 
people with diabetes, as well as increased risk for incident diabetes and diabetes 
complications, including mortality. Periodontal therapy improves serum HbA1C levels and 
is safe to perform, though there is limited evidence for adjunctive therapies. 
Practical Implications 
The oral healthcare team have a role to play in identifying both pre-diabetes and 
undiagnosed diabetes mellitus and physicians need to be aware of periodontal diseases and 
their implications for glycaemic control and complications in people with diabetes. 
Guidelines are documented for physicians, oral healthcare workers, patients and the public. 
 
 
  
Introduction 
Periodontitis is a ubiquitous chronic inflammatory disease, initiated by the accumulation of 
a pathogenic dental plaque biofilm above and below the gingival (gum) margin, and within 
which microbial dysbiosis leads to a chronic non-resolving and destructive inflammatory 
response (Meyle & Chapple 2015, Jepsen et al. 2017). It has a prevalence of 45-50% in 
adults in its mildest form rising to over 60% in people over 65 years of age (64% - Eke et 
al. 2012, 60% - White et al. 2012). Severe periodontitis is estimated to affect 11.2% of the 
global adult population (Kassebaum et al. 2014) and is a major cause of tooth loss, 
nutritional compromise, altered speech, low self-esteem and a poorer overall quality of life 
(Al-Harthi et al. 2013, Buset et al. 2016). Severe periodontitis is also independently 
associated with mortality in several different populations (Garcia et al. 1998, Linden et al. 
2012, Soikkonen et al. 2000, Söder et al. 2007). When present as a co-morbidity in patients 
with chronic kidney disease (CKD), it is associated with a 41% increase in 10-year all-
cause mortality rates and a 22% elevation in 10-year cardiovascular mortality rates (verses 
increases of 36% and 16% in CKD patients without periodontitis) (Sharma et al. 2016). The 
co-morbid presence of periodontitis and diabetes in CKD patients is reported to elevate 10-
year all-cause mortality risk by 23% and cardiovascular mortality risk by 16% in CKD 
patients, with the additional impact on survival when periodontitis is present being 
equivalent to the impact of diabetes as a co-morbid risk factor in CKD (Sharma et al. 2016). 
Diabetes is global epidemic disease. It is estimated there are now more than half a million 
children aged 14 and under living with type 1 diabetes. It is also estimated that there are 
already 415 million adults aged 20-79 with diabetes worldwide, including 193 million who 
are undiagnosed. A further 318 million adults are estimated to have impaired glucose 
tolerance, which puts them at high risk of developing the disease. By the end of 2015, 
diabetes caused 5.0 million deaths and had a cost between USD 673 billion and USD 1,197 
billion in healthcare spending. If this rise is not halted, by 2040 there will be 642 million 
people living with the disease (International Diabetes Federation 2015). 
The significant and independent association between periodontitis and chronic non-
communicable diseases of ageing is widely reported in the literature. Such data provided 
the impetus for an international workshop in 2012, where consensus statements for 
periodontitis and atherogenic cardiovascular disease (Tonetti & Van Dyke 2013), 
periodontitis and diabetes (Chapple & Genco 2013), and periodontitis and adverse 
pregnancy outcomes (Sanz & Kornman 2013) were developed, based upon 10 systematic 
reviews addressing epidemiology, mechanisms of association and periodontal intervention 
studies. A common theme that emerged was the impact of periodontal bacteremia/ 
endotoxemia following daily activities such as eating and tooth brushing upon low-grade 
systemic inflammation, via acute-phase (C-reactive protein, CRP) and neutrophil oxidative 
stress responses. 
 
The evidence base for independent associations between periodontitis and type 2 diabetes is 
long established, with a dual directionality of influence reported (Taylor et al. 2001). In the 
diabetes-periodontitis direction, hyperglycemia is associated with an increased risk and 
severity of periodontitis (Cianciola et al. 1982, Lalla et al. 2006, Emrich et al. 1991, Taylor 
et al. 1998) and poorer periodontal outcomes following periodontal therapy (Mealey 2006). 
Indeed, the addition of periodontal measures, such as suppuration and indicators of 
periodontal disease severity and extent to risk assessment methods for diabetes significantly 
improves screening diagnostic rates. In a United States of America (USA)-based study, 
screening for diabetes in the dental setting was effective in identifying both pre-diabetes 
and diabetes (Albert et al. 2012) and early detection led to the instigation of cost-effective 
lifestyle change measures that resulted in a significant proportion of patients moving from 
pre-diabetes to normo-glycaemia during the trial period. In the United Kingdom, the 
National Institute of Clinical Excellence has suggested that other health care professionals 
other than physicians, including dentists, should be screening for diabetes 
(https://www.nice.org.uk/guidance/ph38/chapter/1-Recommendations# recommendation-1-
risk-assessment). 
 
In the periodontitis-diabetes direction, the 2012 workshop concluded that severe 
periodontitis was associated with significantly elevated serum levels of HbA1C in people 
without diabetes (glycemia) and in those with diabetes (hyperglycemia), and there appeared 
to be a direct relationship between the severity of the periodontitis and cardio-renal 
complications of diabetes (Borgnakke et al. 2013). Severe periodontitis is also associated 
with dyslipidaemia and elevations in oxidative stress markers in the serum of people with 
type 2 diabetes (Allen et al. 2011). Emerging evidence also indicates that people with 
severe periodontitis have an increased risk of developing type 2 diabetes (Saito et al 2004, 
Demmer et al 2008, Morita et al 2012). Finally, in the systematic review aimed at 
addressing the impact of periodontal treatment upon serum HbA1C levels, a mean 
reduction in HbA1C of 0.36% [95% confidence interval (CI) 0.19, 0.54] was demonstrated 
at 3-months (Engebretson & Kocher 2013), a result that was consistent with previous meta-
analyses. 
 
Given the continued global research effort into the periodontitis-diabetes paradigm, this 
joint international workshop between the European Federation of Periodontology (EFP) 
and the International Diabetes Federation (IDF), and involving 15 experts from Europe, the 
USA and South Asia, aimed at developing consensus statements based upon the evidence 
for epidemiological associations, pathogenic mechanisms, and intervention studies of 
periodontal treatment and its impact upon diabetes outcomes. Evidence from 2012 in these 
domains was updated from the systematic reviews of 2012 and the resulting consensus 
statements and guidelines (Chapple & Genco 2013), were also updated to inform the 
development of new guidelines for physicians and their patients, and oral healthcare 
workers and their patients. 
 
The objective of this workshop was to update the evidence base on the bidirectional 
association between periodontitis and type 2 diabetes and provide recommendations for the 
global multidisciplinary team caring for people with diabetes and periodontitis.  
 
Epidemiologic evidence on the effect of periodontitis on diabetes 
Among people without diabetes, is periodontitis associated with elevated glucose levels? 
There is strong evidence for an association between periodontitis and glycemic status, 
expressed as HbA1C, fasting blood glucose levels and/or OGTT in people who have 
no manifest diabetes. People with periodontitis have a higher level of HbA1C 
[weighted mean (WM) of 5.64%; 95% CI, 5.54-5.74%], when compared to people 
with better periodontal health (WM 5.31 %; 95% CI, 5.18-5.44%) where the WM 
difference in HbA1C is 0.29% (95% CI, 0.20-0.37%, p<0.01) (Graziani et al 2017). 
 
Among people with type 2 diabetes, is periodontitis associated with poorer glycemic 
control? 
In three cohort studies (N=1252), including one with a large sample (N=1021), periodontitis 
was significantly associated with poorer glycemic control as measured by HbA1C 
(7.4% vs. 7.0%). This risk was more marked in those patients with poorer HbA1C at 
baseline. By contrast, 4 cross-sectional (N=1076), 1 case-control (N=60) and 1 cohort 
study (N=42) did not report a significant difference of HbA1C levels when 
comparing people with different levels of periodontal status. Some studies, however, 
identified higher insulin resistance (HOMA-IR levels) in people with periodontitis 
(Graziani et al 2017). 
 
Among people with type 1 diabetes, is periodontitis associated with poorer glycemic 
control? 
There is insufficient data (one clinical study) within the current literature to answer this 
question conclusively. 
 
Among people with diabetes, is periodontitis associated with more diabetes complications? 
Diabetes complications studied in relation with periodontitis are: retinopathy 
(background and proliferative), nephropathy (proteinuria and end-stage renal disease), 
neuropathic foot ulceration, various cardiovascular diseases and mortality. The 
overall synthesis is drawn from 13 studies involving 34,149 subjects. 
Retinopathy is significantly associated with periodontitis after adjusting for other 
confounding factors [5 studies; odds ratio (OR) 1.2-2.8]. Emerging evidence indicates 
that the severity of periodontitis correlates significantly with the severity of 
retinopathy. 
There is evidence from three studies that people with periodontitis and with either 
type 1 or type 2 diabetes have significantly more renal complications. In one large 
study, chronic kidney disease (CKD) was associated with significantly more all-cause 
and cardiovascular mortality when periodontitis and diabetes were present at the same 
time as the CKD, than when either were present as individual and independent co-
morbidities in CKD (Sharma et al. 2016). 
 
A significant association of neuropathic foot ulcerations in patients with severe 
periodontitis compared to healthy controls was demonstrated in one study (OR 6.6). 
Cardiovascular complications (cardiovascular mortality, coronary heart disease or 
cerebrovascular events, sub-clinical heart disease) have been significantly associated 
with type 2 diabetes patients suffering from periodontitis [hazard ratios (HR) 1.1 – 
1.3] (OR 2.6). Overall mortality is significantly elevated in patients with type 2 
patients with co-morbid periodontitis (HR 3.5-4.5). 
  
In summary, the majority of studies report a higher association/risk between worse 
periodontal conditions and diabetes complications. 
 
Do people with periodontitis have a greater risk of developing type 2 diabetes than those 
with better periodontal health? 
Overall, evidence from 6 studies representing populations of USA, Japan and Taiwan 
with a total sample of 77,716 participants consistently demonstrated that periodontitis 
patients exhibit a higher chance of developing pre-diabetes and diabetes (adjusted HR 
1.29; 95% CI, 1.11-1.46, p<0.0001) (Graziani et al 2017). 
 
Do women with gestational diabetes and periodontitis have poorer glycaemic control than 
those with better periodontal health? 
There is insufficient data addressing the question of whether periodontitis impairs 
glycemic control in gestational diabetes. 
 
Do pregnant women with periodontitis have a higher incidence of gestational diabetes than 
those with better periodontal health? 
There are no studies assessing whether pregnant women with periodontitis have an 
altered risk of developing gestational diabetes. However, two studies have shown a 
significant association. 
 
Mechanistic Links between Periodontal Diseases and Diabetes 
Is the periodontal microbiota affected by diabetes status? 
Traditional approaches to analyzing the periodontal microbiota did not report 
consistent differences between people with and without diabetes. Emerging evidence 
from small-scale molecular periodontal microbiome studies do indicate an association 
between altered glucose metabolism in pre-diabetes and diabetes and changes in the 
periodontal microbiome. Currently, there is no data supporting a causal relationship 
between the periodontal microbiome and the presence of diabetes. The majority of 
studies address type 2 diabetes (Polak & Shapira et al 2017). 
 
In people with diabetes, what is the role of cytokines and other inflammatory mediators in 
the pathogenesis of periodontitis? 
There is evidence from clinical studies to support the contention that elevated levels 
of pro-inflammatory mediators in poorly controlled diabetes [interleukin (IL) 1-β, 
tumoral necrosis factor (TNF)-α, IL-6, receptor activator of nuclear factor-kappa B 
ligand/osteoprotegerin ratio and oxidative stress] within the gingival tissues of people 
(or animal models) with diabetes play a role in the observed increased periodontal 
destruction. This is supported by studies using cell cultures exposed to high glucose 
levels (Polak & Shapira et al 2017). 
 
Which mechanisms affect the control of diabetes and its complication in people with 
periodontitis? 
There is a moderate level of evidence to support certain biological mechanisms 
mediating the effect of periodontitis on the control of diabetes.  There is evidence for 
reduced beta-cell function, elevated oxidative stress and dyslipidaemia in people with 
type 2 diabetes and periodontitis relative to diabetes alone. Most studies demonstrate 
that circulating pro-inflammatory mediators are elevated in people with diabetes and 
periodontitis, particularly TNF-α, CRP and mediators of oxidative stress.  These pro-
inflammatory mediators may affect the control of diabetes. Unfortunately, there is no 
data from animal studies to support this possibility. 
 
There is no direct evidence for specific mechanisms arising from periodontitis 
impacting upon the complications of diabetes. However, indirect evidence exists for 
common mechanistic pathways (oxidative stress pathways, dyslipidaemia, elevated 
CRP, endothelial dysfunction) that may act synergistically in worsening 
cardiovascular complications in diabetes.  
 
Is there mechanistic evidence that improving the control of diabetes results in improved 
periodontal status? 
There is mechanistic evidence that improving the control of diabetes reduces 
oxidative stress, improves lipid profiles and reduces circulating cytokine levels, 
however, there are no studies relating such biological changes to improvements in 
periodontal status. 
 
Is there mechanistic evidence that improving periodontal health results in improved 
metabolic control and/or complications of diabetes?  
There is evidence from several controlled human studies, which shows that successful 
periodontal treatment reduces circulating levels of CRP and TNF-α in people with 
diabetes (Polak & Shapira et al 2017).  There have been no studies addressing the 
impact of successful long-term periodontal therapy upon the mechanisms involved in 
diabetes complications. 
 
Results of Intervention Studies  
Is it possible to manage periodontitis in people with diabetes? 
Current evidence indicates that in people with diabetes, periodontal therapy accompanied 
by effective home care is both safe and effective. Clinical periodontal parameters and local 
inflammatory measures improve following standard non-surgical therapy even in people 
with poorly controlled diabetes. The benefits of adjunctive treatments (e.g. antimicrobial, 
surgical) needs further investigation, because the majority of previous studies intervened 
using professional mechanical debridement without the use of adjunctive treatments. 
 
Is periodontal treatment effective in improving glycaemic control in people with type 2 diabetes? 
After the previous systematic review by Engebretson & Kocher (2013), at least 7 
randomised clinical trial (RCTs) have been published including a total of 912 patients from 
3 countries (India, Malaysia, USA) (Madianos & Koromantzos 2017). Data from 4 recent 
systematic reviews with meta-analyses (published between 2014 and 2017, with substantial 
but not complete overlap of existing RCTs), have provided consistent evidence for a 
clinically meaningful and statistically significant reduction of HbA1C levels in people with 
type 2 diabetes. The magnitude of reported HbA1C reductions from these meta-analyses 
ranges from 0.27- 0.48% at 3 - 4 months following periodontal therapy.  
There is insufficient data to demonstrate that this effect is maintained at 6 months. 
It should be noted that the reported improvements in HbA1C levels after periodontal 
therapy (currently estimated at 0.27 to 0.48%) are in agreement with the magnitude of 
increase in HbA1C attributed to periodontitis in type 2 diabetics 0.29 % (95% CI, 0.20-0.37 
%) (Madianos & Koromantzos 2017). The increase in glycated hemoglobin due to 
periodontitis is similar in magnitude to the observed improvement once periodontitis is 
treated. 
 
The magnitude of short-term HbA1C reductions obtained following periodontal 
interventions is similar to that often achieved by adding a second medication to a 
pharmacological regimen. If such reductions following periodontal therapy can be 
sustained over the longer term, then this may contribute to reduced diabetes-associated 
morbidity and mortality. 
 
Is periodontal treatment effective in improving glycaemic control in people with type 1 diabetes? 
There is insufficient evidence about the effect of periodontal therapy on HbA1C reduction 
in people with type 1 diabetes due to paucity of studies. The biological plausibility linking 
periodontal therapy to improved glycaemic control among people with type 1 diabetes is 
unclear and requires further exploration. 
 
Do adjunctive antibiotics confer additional benefits and enhance glycemic control? 
The adjunctive use of antibiotics does not enhance HbA1C reduction beyond scaling and 
root planing alone among people with type 2 diabetes. There is insufficient data for the 
adjunctive benefit of antibiotics among people with type 1 diabetes. 
 
What is the specific level of periodontal resolution following periodontal therapy that is 
associated with improvements in diabetes outcomes? 
While periodontal therapies result in reduction in HbA1C levels, people with diabetes, on 
average benefit from periodontal therapy. At present, no specific threshold of periodontal 
disease resolution has been identified as necessary to realize HbA1C reduction.  Thresholds 
of improvement in clinical periodontal parameters necessary to confer meaningful 
reductions of HbA1C levels should be explored in future RCTs. Future meta-analyses could 
use meta-regression approaches to inform this question. 
 
Guidelines 
 
Guidelines for physicians and other medical health professions for use in Diabetes Practice 
Because of the increased risk for developing periodontitis in patients with diabetes 
and the negative impact of periodontitis on diabetes control and complications, the 
following recommendations are made: 
 Oral health education should be provided to all patients with diabetes as part 
of their overall educational program. 
 Patients with all forms of diabetes mellitus should be told that periodontal 
disease risk is increased, and if untreated the periodontitis has a negative 
impact on metabolic control and may also increase the risk of complications 
of their diabetes such as cardiovascular and kidney disease.  
 Patients should be advised that successful periodontal therapy may have a 
positive impact upon their metabolic control and diabetes complications. 
 For people with diabetes, physicians should ask about a prior diagnosis of 
periodontal disease. If a positive diagnosis has been made, the physician 
should seek to ascertain that periodontal care and maintenance are being 
provided. 
 Investigating the presence of periodontal disease should be an integral part of 
a diabetes care visit. People with diabetes should be asked about any signs 
and symptoms of periodontitis, including bleeding gums during brushing or 
eating, loose teeth, spacing or spreading of the teeth, oral malodor, and/or 
abscesses in the gums or gingival suppuration.  
o If a positive history is elicited then a prompt periodontal evaluation 
should be recommended before their scheduled annual check-up.  
o In the case of a negative history, people with diabetes should be 
advised to check for the above symptoms and if a positive sign 
appears they should visit their dentist. 
 For all people with newly diagnosed diabetes mellitus, referral for a 
periodontal examination should occur as part of their ongoing management of 
diabetes. Even if no periodontitis is diagnosed initially, annual periodontal 
review is recommended. 
 For children and adolescents diagnosed with diabetes, annual oral screening 
is recommended through referral to a dental professional. 
 Patients with diabetes who have extensive tooth loss should be encouraged to 
pursue dental rehabilitation to restore adequate mastication for proper 
nutrition. 
 Patients with diabetes should be advised that other oral conditions such as dry 
mouth and burning mouth may occur, and if so, they should seek advice from 
their dental practitioner. Also, patients with diabetes are at increased risk of 
oral fungal infections and experience poorer wound healing than those who 
do not have diabetes. 
 The physician should liaise with the dentist over diabetes management prior 
to the oral intervention and/or surgery in order to avoid hypoglycaemia and to 
consider its potential impact on the patient’s ability to eat. 
i,
 
ii
                                                 
i
 The above guidelines also apply to people with pre-diabetes and the metabolic syndrome. 
ii These guidelines are modified from (Chapple & Genco 2013) and also draw upon 
http://www.aemmedi.it/files/Linee-
guida_Raccomandazioni/2015/Diabete%20e%20Parodontite_AMD_SID_SiDP.pdf 
 
Guidelines for patients with diabetes at the physician’s practice/office 
 
Why should I have my gums checked? 
If your physician has told you that you have diabetes, you should make an 
appointment with a dentist to have your mouth and gums checked. This is because 
people with diabetes have a higher chance of getting gum disease. Gum disease can 
lead to tooth loss and may make your diabetes harder to control. The earlier you seek 
help the better the outcome will be. 
 
What should I look for that may tell me I have problems with my gums? 
You may have gum disease if you have ever noticed: 
 Red or swollen gums; 
 Bleeding from your gums or blood in the sink after you brush your teeth; 
 Foul taste; 
 Longer looking teeth; 
 Loose teeth;  
 Increasing spaces between your teeth; 
  
 Calculus (tartar) on your teeth. 
If you have noticed any of these problems, it is important to see a dentist as soon as 
possible.  
 
Can I have gum disease without these signs being present? 
Gum disease may also be present and get worse with no apparent signs to you, especially if 
you smoke, so even if you do not think you have gum disease now, you should still have 
annual dental check-ups as part of managing your diabetes. Your dentist will be able to pick 
up early signs of gum disease. 
 
What can I do to prevent gum disease? 
You need to clean your teeth and gums twice daily at home for a minimum of two 
minutes. Also, cleaning between your teeth daily is important and your oral health 
professional will show you how to do this. You should visit a dentist as soon as 
possible for a diagnosis and advice on what you need to do. It is important to keep 
your mouth as healthy as possible with regular dental care, according to the 
recommendations of your oral health professional. 
 
What other problems with my mouth should I be looking for? 
If you have diabetes, you may also suffer from dry mouth, burning mouth, or poor 
healing of mouth wounds. 
 
Guidelines for oral health professionals for use in dental practice/office for people 
with diabetes mellitus 
 People with diabetes should be advised that they have an increased risk for 
gingivitis and periodontitis. They should also be told that if they suffer from 
periodontitis, their glycaemic control may be more difficult to achieve, and 
they are at higher risk for other complications such as eye disease, kidney and 
cardiovascular diseases. 
 Collect a careful history to highlight the type of diabetes, duration of the 
disease, the presence of any complications, diabetes therapy and concomitant 
therapies, remembering that most people with diabetes are also being treated 
  
with anticoagulant/antiplatelet drugs, antihypertensive drugs or lipid-lowering 
medications. 
 Ask the patient how well controlled their diabetes is and when they last had 
their blood glucose levels checked. Request that patients bring a copy of their 
last HbA1C result, or that they report their latest results. 
 Oral health education should be provided to all patients with diabetes. This 
should include individualised advice on relevant risk factors and a tailored 
oral hygiene regime, including twice daily brushing, interdental cleaning and 
in some cases the use of adjunctive chemical plaque control may be 
appropriate. 
 People presenting with a diagnosis of any form of diabetes mellitus should 
receive a thorough oral examination, which includes a comprehensive 
periodontal evaluation, to include full mouth pocket chart and bleeding scores 
if indicated by periodontal screening. 
 If no periodontitis is diagnosed initially, patients with diabetes should be 
placed on a preventive care regime and monitored regularly for periodontal 
changes. 
 People with diabetes presenting with any acute oral/periodontal infections 
require prompt oral/periodontal care. 
 If periodontitis is diagnosed, it should be managed without delay. 
immediately. 
 Irrespective of the level of diabetes control, non-surgical periodontal therapy 
should be provided, as this may help to improve glycaemic control. 
 Surgical periodontal and implant therapy is not indicated in patients who do 
not have acceptable diabetes control. In well-controlled patients, the results of 
surgical interventions are equivalent to patients without diabetes. However, 
attention should be paid to: 
  
o people with poorly controlled diabetes, who have an increased risk of 
post-operative infections; 
o patients managed with insulin or sulfonylureas, when the physician 
should be consulted about the timing of the planned procedure and a 
possible change in dosage of therapy to reduce the risk of 
intraoperative hypoglycaemia; 
 People with diabetes who have extensive tooth loss should be encouraged to 
pursue dental rehabilitation to restore adequate mastication for proper 
nutrition. 
 People with diabetes should also be evaluated for other potential oral 
complications, including dry mouth, burning mouth, candida infections and 
dental caries. 
 For children and adolescents diagnosed with diabetes, an annual oral 
screening for early signs of periodontal involvement and dental caries is 
recommended starting as early as possible. 
 Patients who present in the dental surgery/office without a diagnosis of 
diabetes, but with risk factors for type 2 diabetes should be informed about 
their risk for having diabetes and referred to a physician for appropriate 
diagnostic testing and follow-up care. 
o Patients risk may be screened for using a validated questionnaire. For 
example, in a Causcasian population (FindRisk Questionnaire - 
http://www.idf.org/webdata/docs/FINDRISC_English.pdf) – appendix 
1 
o For oral health professionals with a special interest in diabetes, they 
may wish to consider screening based upon the recommendations of 
the American Diabetes Association (Diabetes Care 2017) – appendix 
2 
  
o If symptomatic (polydipsia, polyuria, polyphagia, unexplained weight 
loss), refer directly to a physician. 
 
Guidelines for patients at the dental surgery/office who have diabetes or are found 
to be at risk for diabetes 
 People with diabetes have a higher chance of getting gum disease.  
 You may think that you are doing well managing your gum health, but you 
may not be doing enough because you have an increased risk of gum 
problems. 
 Like diabetes, gum disease is a chronic condition and requires lifelong 
maintenance. 
 You also need to clean your teeth and gums very carefully at home. 
Personalised advice will be provided by your oral health professional. This 
may include: 
o  twice daily brushing with either manual or electric toothbrush 
o cleaning between your teeth using interdental brushes where they fit; 
where they do not fit, then flossing may be useful 
o the use of specific dentifrices and/or mouth rinses with proven activity 
against dental plaque, if advised by oral health professionals. 
 If left untreated, gum disease can lead to tooth loss and may also make your 
diabetes harder to control. 
 Gum disease may be present and get worse with no apparent symptoms to 
you, so if your dentist told you that you do not have gum disease now, you 
should still get regular dental check-ups as part of managing your diabetes. 
Your dentist will be able to pick up early signs of gum disease. 
 You may have gum disease if you have ever noticed: 
o Red or swollen gums; 
  
o Bleeding from your gums or blood in the sink after you brush your 
teeth; 
o Foul taste; 
o Longer looking teeth; 
o Loose teeth;  
o Increasing spaces between your teeth; 
o Calculus (tartar) on your teeth. 
 
 People with diabetes may also suffer from dry mouth, burning mouth, yeast 
infections of the mouth or poor healing of mouth wounds. 
 Remember to inform your dentist about the outcome of your visits to your 
doctor and provide an update of the results of your diabetes control and 
changes in medications. 
 It is important to keep your mouth and your whole body as healthy as 
possible with regular dental and medical care. 
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Appendix 1: FindRisk Questionnaire (Lindstrom & Tuomilehto 2003)  
 
  
  
  
Appendix 2: Criteria for Screening according to the recommendations of the 
American Diabetes Association (Diabetes Care 2017) 
 
 
 
 
 
 
 
Table 1 – Criteria for testing for diabetes or prediabetes in asymptomatic adults 
From Diabetes Care 2017. 
1. Testing should be considered in overweight or obese (BMI≥25kg/m2 or 
≥23kg/m2 in Asian American) adults who have one or more of the following 
risk factors: 
 AIC ≥5.7% (39mmol/mol), IGT, IFG on previous testing 
 First degree relative with diabetes 
 High-risk race/ethnicity (e.g., African American, Latino, Native American, 
Asian American, Pacific Islander) 
 Women who were diagnosed with GDM 
 History of CVD 
 Hypertension (≥140/90mmHg or on therapy for hypertension) 
 HDL colesterol level <35mg/dL) and/or a triglyceride level >250mg/dL 
(2.82 mmol/L) 
 Women with polycystic ovary syndrome  
 Physical inactivity 
 Other clinical conditions associated with insulin resistance (eg severe 
obesity, acanthosis nigricans). 
2. For all patients, disease testing should begin at age 45 years 
3. If results are normal, testing should be repeated at a mínimum of 3-year 
intervals, with consideration of more frequent testing depending on initial 
results (e.g, those with prediabetes should be tested yearly) and risk status. 
 
